As on December 23, 2020, Predictive Oncology Inc. (NASDAQ: POAI) got off with the flyer as it spiked 16.50% to $0.77. During the day, the stock rose to $0.92 and sunk to $0.66 before settling in for the price of $0.66 at the close. Taking a more long-term approach, POAI posted a 52-week range of $0.63-$5.30.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 8.20%. Meanwhile, its Annual Earning per share during the time was 58.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 12.90%. This publicly-traded company’s shares outstanding now amounts to $17.68 million, simultaneously with a float of $16.16 million. The organization now has a market capitalization sitting at $13.61 million. At the time of writing, stock’s 50-day Moving Average stood at $0.7227, while the 200-day Moving Average is $1.2248.
If we measure the efficiency of the company that is accounted for 29 employees. It has generated 44,111 per worker during the last fiscal year. Meanwhile, its income per employee was -605,961. The stock had 2.75 Receivables turnover and 0.11 Total Asset turnover. For the Profitability, stocks gross margin was +12.39, operating margin was -975.83 and Pretax Margin of -1373.71.
Predictive Oncology Inc. (POAI) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Medical Instruments & Supplies industry. Predictive Oncology Inc.’s current insider ownership accounts for 9.30%, in contrast to 2.20% institutional ownership. According to the most recent insider trade that took place on Oct 22, this organization’s Chief Executive Officer sold 640 shares at the rate of 0.85, making the entire transaction reach 544 in total value, affecting insider ownership by 1,611,341. Preceding that transaction, on Sep 01, Company’s Director bought 4,000 for 0.90, making the whole transaction’s value amount to 3,602. This particular insider is now the holder of 12,070 in total.
Predictive Oncology Inc. (POAI) Earnings and Revenue Records
This company achieved a net margin of -1373.71 while generating a return on equity of -343.66. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Predictive Oncology Inc.’s EPS increase for this current 12-month fiscal period is 12.90%.
Predictive Oncology Inc. (NASDAQ: POAI) Trading Performance Indicators
Let’s observe the current performance indicators for Predictive Oncology Inc. (POAI). It’s Quick Ratio in the last reported quarter now stands at 0.30. The Stock has managed to achieve an average true range (ATR) of 0.06. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10.47.
In the same vein, POAI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.41.
Technical Analysis of Predictive Oncology Inc. (POAI)
Through scrutinizing the latest numbers posted by the [Predictive Oncology Inc., POAI], it can be observed that its last 5-days Average volume of 2.69 million was better the volume of 0.91 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 21.17% While, its Average True Range was 0.0710.
Raw Stochastic average of Predictive Oncology Inc. (POAI) in the period of the previous 100 days is set at 11.98%, which indicates a major fall in contrast to 44.07% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 82.11% that was higher than 66.80% volatility it exhibited in the past 100-days period.